OBJECTIVE: To update the 1997 clinical practice guidelines for the use of tumor marker
tests in the prevention, screening, treatment, and surveillance of breast and colorectal …

Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of gastrointestinal cancers. Methods For the 2006 …

Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Testing for tumour markers should only be performed if it results in a better patient outcome,
increased quality of life or reduced overall cost of care. Ideally, the clinical value of a tumour …

Background: Increasing interest in implementing the practice of evidence-based medicine in
oncology has encouraged the development of clinical guidelines, many of which include …

In recent years, numerous serum and cell/tissue-based markers have been described for
colorectal cancer (CRC). The aim of this article was to provide guidelines for the routine …

The molecular analysis of biomarkers in oncology is rapidly advancing, but the incorporation
of new molecular tests into clinical practice will require a greater understanding of the …

Clinical management decisions for patients with cancer are increasingly being guided by
prognostic and predictive markers. Use of these markers should be based on a sufficiently …

Despite years of research and hundreds of reports on tumor markers in oncology, the
number of markers that have emerged as clinically useful is pitifully small. 1-3 Often, initially …

Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an …